Applied Medical Software Inc is categorized under Prepackaged Software in Collingswood, NJ and active since 2005.
Applied Medical Software Inc was established in 2005, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Prepackaged Software business, which does work in the BOTH market, and is classified as a Prepackaged Software, under code number 4431424 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 595 Haddon Avenue, Collingswood, New Jersey NJ 08108 or by phoning (856) 858-3822. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Applied Medical Software Inc |
| Address: | 595 Haddon Avenue, Collingswood, New Jersey 08108 |
| Phone Number: | (856) 858-3822 |
| Website Address: | appliedmedicalsoftware.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | Prepackaged Software |
| SIC Code: | 7372 |
| NAICS Code: | 4431424 |
| Share This Business: |
Applied Medical Software Inc was started in 2005 to provide professional Prepackaged Software under the SIC code 7372 and NAICS code 4431424. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact for inquiries that concern Applied Medical Software Inc by calling the company number (856) 858-3822, as your correspondence is most welcome. Additionally, the physical location of the single location of Applied Medical Software Inc can be found at the coordinates 39.917265,-75.071841 as well as the street address 595 Haddon Avenue in Collingswood, New Jersey 08108.
For its online presence, you may visit Applied Medical Software Inc’s website at appliedmedicalsoftware.com and engage with its social media outlets through on Twitter and on Facebook.